Continental Services Group, Inc. – FDA 483, Jun 29, 2026

Continental Services Group, Inc. in Miami, FL, a blood bank establishment, was cited for three significant observations during an FDA inspection. The firm failed to properly investigate severe adverse donor reactions and conduct required follow-ups. Additionally, deficiencies were noted in the quality control and calibration of centrifuges used for blood processing, and in maintaining complete records identifying personnel and dates for work performed, specifically for source plasma donor records.